BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10904249)

  • 1. Cytokines in rheumatoid arthritis: trials and tribulations.
    Carteron NL
    Mol Med Today; 2000 Aug; 6(8):315-23. PubMed ID: 10904249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological insights from clinical trials with anti-TNF therapy.
    Feldmann M; Charles P; Taylor P; Maini RN
    Springer Semin Immunopathol; 1998; 20(1-2):211-28. PubMed ID: 9836378
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis.
    Hamilton K; Clair EW
    Expert Opin Pharmacother; 2000 Jul; 1(5):1041-52. PubMed ID: 11249494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of rheumatoid arthritis by TNF-blocking agents.
    Graninger W; Smolen J
    Int Arch Allergy Immunol; 2002 Jan; 127(1):10-4. PubMed ID: 11893849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular differences in anticytokine therapies.
    Calabrese LH
    Clin Exp Rheumatol; 2003; 21(2):241-8. PubMed ID: 12747285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis.
    McInnes IB; Gracie JA
    Curr Rheumatol Rep; 2004 Oct; 6(5):336-42. PubMed ID: 15355745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor inhibitors: new options for treating rheumatoid arthritis.
    Moreland LW
    Isr Med Assoc J; 2001 Sep; 3(9):686-90. PubMed ID: 11574988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects].
    Botsios C; Ostuni P; Sfriso P; Furlan A; Fiocco U; Sgarabotto D; Todesco S
    Reumatismo; 2003; 55(4):224-35. PubMed ID: 14872221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept in rheumatoid arthritis.
    Alldred A
    Expert Opin Pharmacother; 2001 Jul; 2(7):1137-48. PubMed ID: 11583065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.
    Cole P; Rabasseda X
    Drugs Today (Barc); 2004 Apr; 40(4):281-324. PubMed ID: 15190385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recombinant proteins or monoclonal antibodies: comparative properties and interest in rheumatoid arthritis].
    Sibilia J
    Med Sci (Paris); 2009 Dec; 25(12):1033-8. PubMed ID: 20035675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokines and anti-cytokine therapy in rheumatoid arthritis].
    Lorenz HM; Kalden JR
    Internist (Berl); 2001 Jan; 42(1):55-6, 59-63. PubMed ID: 11271621
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of inflammatory immunologic disease 3. Anti-TNF therapy in rheumatoid arthritis.
    Takeuchi T
    Intern Med; 2007; 46(16):1311-2. PubMed ID: 17704613
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of new biologicals in the treatment of rheumatoid arthritis.
    Weaver AL
    Rheumatology (Oxford); 2004 Jun; 43 Suppl 3():iii17-iii23. PubMed ID: 15150428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR; Keating GM
    Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic use of "biologics" in inflammatory joint and spinal diseases].
    Seitz M
    Ther Umsch; 2002 Oct; 59(10):535-43. PubMed ID: 12428439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept.
    Mikuls TR; Moreland LW
    Expert Opin Pharmacother; 2001 Jan; 2(1):75-84. PubMed ID: 11336570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological response modifiers in the management of rheumatoid arthritis.
    Louie SG; Park B; Yoon H
    Am J Health Syst Pharm; 2003 Feb; 60(4):346-55. PubMed ID: 12625216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.